PRESS RELEASE published on 11/07/2025 at 09:55, 11 months 15 days ago Original-Research: Zalando SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy Quirin Privatbank Kapitalmarktgeschäft issues Buy recommendation for Zalando SE with target price of EUR 38.40. Q3-25 shows solid growth with GMV up by 21.6% and revenue by 26.5%. Strong B2B segment performance. Analyst: Ralf Marinoni Buy Recommendation Zalando SE Solid Growth Quirin Privatbank Q3-25
PRESS RELEASE published on 11/07/2025 at 09:35, 11 months 15 days ago ADOIT 18.0: Redefining Enterprise Architecture with Built-In Intelligence BOC Group launches ADOIT 18.0, the latest Enterprise Architecture suite with AI-powered features for enhanced insights and governance Governance AI-powered Enterprise Architecture BOC Group ADOIT 18.0
PRESS RELEASE published on 11/07/2025 at 09:01, 11 months 15 days ago Original-Research: Nynomic AG (von NuWays AG): Buy Nynomic AG's Q3 preliminary results show signs of recovery, with improved order intake and positive EBIT. Sales guidance lowered for FY25, but positive outlook with efficiency program EBIT Order Intake Q3 Results Nynomic AG Efficiency Program
PRESS RELEASE published on 11/07/2025 at 09:01, 11 months 15 days ago Original-Research: Deutsche Beteiligungs AG (von NuWays AG): Buy Deutsche Beteiligungs AG analysis reveals solid Q3 performance, high deal activity, and positive outlook with buy recommendation at EU 39.00 PT Buy Recommendation Deutsche Beteiligungs AG Analysis Q3 Performance High Deal Activity
PRESS RELEASE published on 11/07/2025 at 09:00, 11 months 15 days ago Original-Research: The Platform Group AG (von NuWays AG): Buy The Platform Group AG releases strong Q3 results, showing significant growth in sales and profitability. Analysts recommend buying with a target price of EUR 21.00 Profitability Sales Growth Q3 Results The Platform Group AG Analyst Recommendations
PRESS RELEASE published on 11/07/2025 at 09:00, 11 months 15 days ago Original-Research: Multitude AG (von NuWays AG): Buy Multitude AG, previously NuWays AG, to release Q3'25 figures. Expected sales up 3% yoy, net profit solid at €6.9m. Focus on brokerage business and diversified income streams Sales Net Profit Multitude AG Brokerage Business Q3'25
PRESS RELEASE published on 11/07/2025 at 09:00, 11 months 15 days ago Original-Research: DEMIRE AG (von NuWays AG): Buy NuWays AG research report on DEMIRE AG highlights stable operational performance with Q3 results in line. Stock recommendation upgraded to Buy with a new PT of EUR 1.00 DEMIRE AG Operational Performance NuWays AG Research Report Stock Recommendation
PRESS RELEASE published on 11/07/2025 at 09:00, 11 months 15 days ago Original-Research: Westwing Group SE (von NuWays AG): Buy NuWays AG upgrades Westwing Group SE to Buy with a target price of EUR 22.00 following the strong Q3 performance. Significant growth in topline and gross margin fuel positive outlook for FY '25 NuWays AG Westwing Group SE Target Price Q3 Performance FY '25 Outlook
PRESS RELEASE published on 11/07/2025 at 09:00, 11 months 15 days ago Taipei Captures Attention at WTM London with Culture, Nature and a Safe Travel Experience WTM London 2025 spotlights Taipei as a must-visit destination with diverse attractions and accolades, inviting European travellers for a unique urban-nature experience Safety Travel Destination WTM London 2025 Taipei Urban-nature Experience
PRESS RELEASE published on 11/07/2025 at 09:00, 11 months 15 days ago Official List Notice Financial Conduct Authority admits multiple securities to the Official List in various categories and classes. Includes Petra Diamonds, Invesco, iShares, capAI, Graniteshares, Xtrackers, 21Shares, Alkemy Capital, Solvonis Therapeutics, and more Securities Financial Conduct Authority Debt Securities Equity Shares Official List Notice
Published on 10/23/2026 at 02:20, 4 hours 37 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 7 hours 27 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 8 hours 27 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 14 hours 57 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 16 hours 27 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 06:45, 12 minutes ago GURIT REPORTS SOLID THIRD-QUARTER PERFORMANCE AND REITERATES FULL-YEAR GUIDANCE
Published on 10/23/2026 at 06:30, 27 minutes ago HBM Healthcare Investments publishes Half-Year Report as at 30 September 2026 with key figures for the first six months of the 2026/2027 financial year
Published on 10/23/2026 at 06:30, 27 minutes ago Double-digit organic growth in recurring EBIT of 11.8% with margin expansion and guidance upgrade
Published on 10/23/2026 at 06:05, 52 minutes ago Baccarat Hotel & Residences Maldives Unveils New Campaign featuring Adriana Lima
Published on 10/23/2026 at 01:55, 5 hours 2 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 18:00, 12 hours 57 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 12 hours 57 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 12 hours 57 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 12 hours 57 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 12 hours 57 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
